ICI 182,780 induces P-cadherin overexpression in breast cancer cells through chromatin remodelling at the promoter level

A role for C/EBPβ in CDH3 gene activation

André Albergaria, Ana Sofia Ribeiro, Sandra I. Pinho, Fernanda Milanezi, Vítor Carneiro, Bárbara Sousa, Sónia Sousa, Carla Oliveira, José Carlos Machado, Raquel Seruca, Joana Paredes, Fernando Schmitt

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

CDH3/P-cadherin is a classical cadherin. Overexpression of which has been associated with proliferative lesions of high histological grade, decreased cell polarity and poor survival of patients with breast cancer. In vitro studies showed that it can be up-regulated by ICI 182,780, suggesting that the lack of ERα signalling is responsible for the aberrant P-cadherin overexpression and for its role in inducing breast cancer cell invasion and migration. However, the mechanism by which ER-signalling inhibition leads to P-cadherin expression is still unknown. The aim of this study was to explore the molecular mechanism linking the ERα-signalling and P-cadherin-regulated expression in breast cancer cell lines. This study showed that ICI 182,780 is able to increase CDH3 promoter activity, inducing high levels of the active chromatin mark H3 lysine 4 dimethylation. We also observed, for the first time, that the transcription factor C/EBPβ is able to up-regulate CDH3 promoter activity in breast cancer cells. Moreover, we showed that the expression of P-cadherin and C/EBPβ are highly associated in human breast carcinomas and linked with a worse prognosis of breast cancer patients. This study demonstrates the existence of an epigenetic regulation by which ICI 182,780 up-regulates P-cadherin expression in MCF-7/AZ breast cancer cells through chromatin remodelling at CDH3 promoter, bringing forward the growing evidence that ERα signalling-abrogation by anti-oestrogens is able to induce the expression of ERα-repressed genes which, in the appropriate cell biology context, may contribute to a breast cancer cell invasion phenotype.

Original languageEnglish (US)
Article numberddq134
Pages (from-to)2554-2566
Number of pages13
JournalHuman Molecular Genetics
Volume19
Issue number13
DOIs
StatePublished - Apr 12 2010
Externally publishedYes

Fingerprint

Chromatin Assembly and Disassembly
Cadherins
Transcriptional Activation
Breast Neoplasms
Up-Regulation
Cell Polarity
fulvestrant
Epigenomics
Lysine
Chromatin
Cell Movement
Cell Biology
Estrogens
Transcription Factors
Phenotype
Cell Line
Survival

ASJC Scopus subject areas

  • Genetics
  • Genetics(clinical)
  • Molecular Biology

Cite this

ICI 182,780 induces P-cadherin overexpression in breast cancer cells through chromatin remodelling at the promoter level : A role for C/EBPβ in CDH3 gene activation. / Albergaria, André; Ribeiro, Ana Sofia; Pinho, Sandra I.; Milanezi, Fernanda; Carneiro, Vítor; Sousa, Bárbara; Sousa, Sónia; Oliveira, Carla; Machado, José Carlos; Seruca, Raquel; Paredes, Joana; Schmitt, Fernando.

In: Human Molecular Genetics, Vol. 19, No. 13, ddq134, 12.04.2010, p. 2554-2566.

Research output: Contribution to journalArticle

Albergaria, A, Ribeiro, AS, Pinho, SI, Milanezi, F, Carneiro, V, Sousa, B, Sousa, S, Oliveira, C, Machado, JC, Seruca, R, Paredes, J & Schmitt, F 2010, 'ICI 182,780 induces P-cadherin overexpression in breast cancer cells through chromatin remodelling at the promoter level: A role for C/EBPβ in CDH3 gene activation', Human Molecular Genetics, vol. 19, no. 13, ddq134, pp. 2554-2566. https://doi.org/10.1093/hmg/ddq134
Albergaria, André ; Ribeiro, Ana Sofia ; Pinho, Sandra I. ; Milanezi, Fernanda ; Carneiro, Vítor ; Sousa, Bárbara ; Sousa, Sónia ; Oliveira, Carla ; Machado, José Carlos ; Seruca, Raquel ; Paredes, Joana ; Schmitt, Fernando. / ICI 182,780 induces P-cadherin overexpression in breast cancer cells through chromatin remodelling at the promoter level : A role for C/EBPβ in CDH3 gene activation. In: Human Molecular Genetics. 2010 ; Vol. 19, No. 13. pp. 2554-2566.
@article{b4e7d7b31a584c2bb3568ca21abb3499,
title = "ICI 182,780 induces P-cadherin overexpression in breast cancer cells through chromatin remodelling at the promoter level: A role for C/EBPβ in CDH3 gene activation",
abstract = "CDH3/P-cadherin is a classical cadherin. Overexpression of which has been associated with proliferative lesions of high histological grade, decreased cell polarity and poor survival of patients with breast cancer. In vitro studies showed that it can be up-regulated by ICI 182,780, suggesting that the lack of ERα signalling is responsible for the aberrant P-cadherin overexpression and for its role in inducing breast cancer cell invasion and migration. However, the mechanism by which ER-signalling inhibition leads to P-cadherin expression is still unknown. The aim of this study was to explore the molecular mechanism linking the ERα-signalling and P-cadherin-regulated expression in breast cancer cell lines. This study showed that ICI 182,780 is able to increase CDH3 promoter activity, inducing high levels of the active chromatin mark H3 lysine 4 dimethylation. We also observed, for the first time, that the transcription factor C/EBPβ is able to up-regulate CDH3 promoter activity in breast cancer cells. Moreover, we showed that the expression of P-cadherin and C/EBPβ are highly associated in human breast carcinomas and linked with a worse prognosis of breast cancer patients. This study demonstrates the existence of an epigenetic regulation by which ICI 182,780 up-regulates P-cadherin expression in MCF-7/AZ breast cancer cells through chromatin remodelling at CDH3 promoter, bringing forward the growing evidence that ERα signalling-abrogation by anti-oestrogens is able to induce the expression of ERα-repressed genes which, in the appropriate cell biology context, may contribute to a breast cancer cell invasion phenotype.",
author = "Andr{\'e} Albergaria and Ribeiro, {Ana Sofia} and Pinho, {Sandra I.} and Fernanda Milanezi and V{\'i}tor Carneiro and B{\'a}rbara Sousa and S{\'o}nia Sousa and Carla Oliveira and Machado, {Jos{\'e} Carlos} and Raquel Seruca and Joana Paredes and Fernando Schmitt",
year = "2010",
month = "4",
day = "12",
doi = "10.1093/hmg/ddq134",
language = "English (US)",
volume = "19",
pages = "2554--2566",
journal = "Human Molecular Genetics",
issn = "0964-6906",
publisher = "Oxford University Press",
number = "13",

}

TY - JOUR

T1 - ICI 182,780 induces P-cadherin overexpression in breast cancer cells through chromatin remodelling at the promoter level

T2 - A role for C/EBPβ in CDH3 gene activation

AU - Albergaria, André

AU - Ribeiro, Ana Sofia

AU - Pinho, Sandra I.

AU - Milanezi, Fernanda

AU - Carneiro, Vítor

AU - Sousa, Bárbara

AU - Sousa, Sónia

AU - Oliveira, Carla

AU - Machado, José Carlos

AU - Seruca, Raquel

AU - Paredes, Joana

AU - Schmitt, Fernando

PY - 2010/4/12

Y1 - 2010/4/12

N2 - CDH3/P-cadherin is a classical cadherin. Overexpression of which has been associated with proliferative lesions of high histological grade, decreased cell polarity and poor survival of patients with breast cancer. In vitro studies showed that it can be up-regulated by ICI 182,780, suggesting that the lack of ERα signalling is responsible for the aberrant P-cadherin overexpression and for its role in inducing breast cancer cell invasion and migration. However, the mechanism by which ER-signalling inhibition leads to P-cadherin expression is still unknown. The aim of this study was to explore the molecular mechanism linking the ERα-signalling and P-cadherin-regulated expression in breast cancer cell lines. This study showed that ICI 182,780 is able to increase CDH3 promoter activity, inducing high levels of the active chromatin mark H3 lysine 4 dimethylation. We also observed, for the first time, that the transcription factor C/EBPβ is able to up-regulate CDH3 promoter activity in breast cancer cells. Moreover, we showed that the expression of P-cadherin and C/EBPβ are highly associated in human breast carcinomas and linked with a worse prognosis of breast cancer patients. This study demonstrates the existence of an epigenetic regulation by which ICI 182,780 up-regulates P-cadherin expression in MCF-7/AZ breast cancer cells through chromatin remodelling at CDH3 promoter, bringing forward the growing evidence that ERα signalling-abrogation by anti-oestrogens is able to induce the expression of ERα-repressed genes which, in the appropriate cell biology context, may contribute to a breast cancer cell invasion phenotype.

AB - CDH3/P-cadherin is a classical cadherin. Overexpression of which has been associated with proliferative lesions of high histological grade, decreased cell polarity and poor survival of patients with breast cancer. In vitro studies showed that it can be up-regulated by ICI 182,780, suggesting that the lack of ERα signalling is responsible for the aberrant P-cadherin overexpression and for its role in inducing breast cancer cell invasion and migration. However, the mechanism by which ER-signalling inhibition leads to P-cadherin expression is still unknown. The aim of this study was to explore the molecular mechanism linking the ERα-signalling and P-cadherin-regulated expression in breast cancer cell lines. This study showed that ICI 182,780 is able to increase CDH3 promoter activity, inducing high levels of the active chromatin mark H3 lysine 4 dimethylation. We also observed, for the first time, that the transcription factor C/EBPβ is able to up-regulate CDH3 promoter activity in breast cancer cells. Moreover, we showed that the expression of P-cadherin and C/EBPβ are highly associated in human breast carcinomas and linked with a worse prognosis of breast cancer patients. This study demonstrates the existence of an epigenetic regulation by which ICI 182,780 up-regulates P-cadherin expression in MCF-7/AZ breast cancer cells through chromatin remodelling at CDH3 promoter, bringing forward the growing evidence that ERα signalling-abrogation by anti-oestrogens is able to induce the expression of ERα-repressed genes which, in the appropriate cell biology context, may contribute to a breast cancer cell invasion phenotype.

UR - http://www.scopus.com/inward/record.url?scp=77954172745&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77954172745&partnerID=8YFLogxK

U2 - 10.1093/hmg/ddq134

DO - 10.1093/hmg/ddq134

M3 - Article

VL - 19

SP - 2554

EP - 2566

JO - Human Molecular Genetics

JF - Human Molecular Genetics

SN - 0964-6906

IS - 13

M1 - ddq134

ER -